Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 01, 2017 08:00 ET | Source: Chiasma, Inc.

Chiasma to Present at the Cowen and Company 37th Annual Health Care Conference

WALTHAM, Mass., March 01, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic...
January 09, 2017 08:00 ET | Source: Chiasma, Inc.

Chiasma Provides Year-End Corporate Update and Preliminary Outlook for 2017

WALTHAM, Mass., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
November 09, 2016 16:05 ET | Source: Chiasma, Inc.

Chiasma Provides Corporate Update and Reports Third Quarter 2016 Results

WALTHAM, Mass., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
November 01, 2016 08:00 ET | Source: Chiasma, Inc.

Chiasma Recognizes Acromegaly Awareness Day with New Resources for Patients and Data Presentation for Physicians

Data from a Novel Patient-Reported Outcome Tool Assessing Acromegaly Treatment Satisfaction to be Presented Tools for Patients Added to Acromegaly.care WALTHAM, Mass., Nov. 01, 2016 (GLOBE...
September 30, 2016 16:15 ET | Source: Chiasma, Inc.

Chiasma Names Mark J. Fitzpatrick Chief Executive Officer

WALTHAM, Mass., Sept. 30, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
August 16, 2016 09:00 ET | Source: Chiasma, Inc.

Chiasma Announces Workforce Reduction

WALTHAM, Mass., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
August 10, 2016 16:02 ET | Source: Chiasma, Inc.

Chiasma Provides Corporate Update and Reports Second Quarter 2016 Results

WALTHAM, Mass., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
July 27, 2016 08:00 ET | Source: Chiasma, Inc.

Chiasma to Report Second Quarter 2016 Financial Results on August 10, 2016

WALTHAM, Mass., July 27, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
June 14, 2016 09:00 ET | Source: Chiasma, Inc.

Chiasma Announces Corporate Restructuring Plan and Provides Regulatory Update Regarding Mycapssa™

WALTHAM, Mass., June 14, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases, today...
May 31, 2016 08:00 ET | Source: Chiasma, Inc.

Chiasma to Present at Jefferies Global Healthcare Conference

WALTHAM, Mass., May 31, 2016 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ:CHMA), a biopharmaceutical company developing an investigational new drug, Mycapssa™ (octreotide) capsules, for the potential...